XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$0.91
-0.01 (-1.09%)
Open$0.90
Previous Close$0.92
Day High$0.95
Day Low$0.86
52W High$4.83
52W Low$2.42
Volume—
Avg Volume480
Market Cap2.37M
P/E Ratio—
EPS$-2.65
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+4,585.7% upside
Current
$0.91
$0.91
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 77.33M | 96.89M | 1.25M |
| Net Income | -7,315,175 | -8,249,163 | 338.7K |
| Profit Margin | -2.6% | -2.5% | 27.0% |
| EBITDA | -8,662,845 | -10,311,618 | 499.5K |
| Free Cash Flow | — | — | 161.5K |
| Rev Growth | -20.2% | -20.2% | +20.7% |
| Debt/Equity | 0.02 | 0.02 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |